“…Although mHTRs are becoming the preferred approach to treating intrauterine pathology, the resectoscope continues to be an important tool, particularly in the setting of type 2 submucosal myomas. 31 The prevalence of complications is low for mHTR, reported at 0.02% for inhospital procedures and 1.6% when used in the office setting. 32 When compared with the resectoscope, the mHTR system is associated with fewer complications such as uterine perforation, bleeding, and fluid overload, which can be life threatening.…”